# ë°°ê²½ ìë£Œ: S2 ì‹ì´-ë§ˆì´í¬ë¡œë°”ì´ì˜´-ê±´ê°• ìƒí˜¸ì‘ìš©

**ì„¸ì…˜**: S2 - Transforming Human Health through Diet-Microbiome-Host Interactions
**ì¼ì‹œ**: 2025ë…„ 10ì›” 26ì¼ (ì¼) 13:30-15:30
**ì¥ì†Œ**: Rm 301+302
**ì¤‘ìš”ë„**: â­â­ (75/100ì )

---

## ğŸ¯ ì„¸ì…˜ ê°œìš”

ì´ ì„¸ì…˜ì€ **ì‹ì´ê°€ ë§ˆì´í¬ë¡œë°”ì´ì˜´ êµ¬ì„±ì„ í˜•ì„±í•˜ê³  ì¸ê°„ ê±´ê°•ì— ë¯¸ì¹˜ëŠ” ì˜í–¥**ì„ ë‹¤ë£¹ë‹ˆë‹¤. ì§„ë‹¨ ì‘ìš©(íƒ€ì•¡ ë§ˆì´í¬ë¡œë°”ì´ì˜´), ëŒ€ì‚¬ ê¸°ëŠ¥(ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬), ì •ì°© ì „ëµ, ì‹ì´-ì§ˆë³‘ ìƒí˜¸ì‘ìš©ì„ í¬ê´„í•©ë‹ˆë‹¤.

### ì™œ ì´ ì„¸ì…˜ì´ ì¤‘ìš”í•œê°€?

- ğŸ”¬ **ë¹„ì¹¨ìŠµì  ì§„ë‹¨**: íƒ€ì•¡ ë§ˆì´í¬ë¡œë°”ì´ì˜´ì„ í†µí•œ ì§ˆë³‘ ë°”ì´ì˜¤ë§ˆì»¤
- ğŸ¦  **ëŒ€ì‚¬ ë©”ì»¤ë‹ˆì¦˜**: ì¥ë‚´ ì„¸ê· ì˜ ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ê°€ ê±´ê°•ì— ë¯¸ì¹˜ëŠ” ì˜í–¥
- ğŸŒ **ì„ìƒ ì‘ìš©**: ì‹ì´ ì¡°ì ˆì„ í†µí•œ ë§ˆì´í¬ë¡œë°”ì´ì˜´ modulation
- ğŸ’Š **ì •ë°€ ì˜ì–‘í•™**: ê°œì¸ ë§ì¶¤í˜• ì‹ì´ ì „ëµ

---

## ğŸ“‹ ë°œí‘œë³„ ìƒì„¸ ë¶„ì„

### ğŸ”¹ ë°œí‘œ 1 (13:30-14:00)

**ì—°ì‚¬**: Jin-Woo Bae (ë°°ì§„ìš°)
**ì†Œì†**: Kyung Hee University (ê²½í¬ëŒ€í•™êµ)
**ì œëª©**: Salivary microbiome profiling for disease diagnosis

#### ì—°êµ¬ ë°°ê²½

**í•µì‹¬ ì—°êµ¬ ë°©í–¥**:
- êµ¬ê°• ë§ˆì´í¬ë¡œë°”ì´ì˜´ì—ì„œ ë¹„ì¹¨ìŠµì  ì§„ë‹¨ ë°”ì´ì˜¤ë§ˆì»¤ ë°œêµ´
- ì „ì‹  ì§ˆí™˜ì— ëŒ€í•œ íƒ€ì•¡ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ì‹œê·¸ë‹ˆì²˜
- ì¡°ê¸° ì§ˆë³‘ ê²€ì¶œ ì‘ìš©

**ì™œ ì¤‘ìš”í•œê°€**:
- **ì ‘ê·¼ì„±**: ì¥ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ìƒ˜í”Œë§ë³´ë‹¤ ì‰¬ì›€ (ì¹¨ë§Œ í•„ìš”)
- **ì„ìƒ ì‘ìš© ê°€ëŠ¥ì„±**: ê°„ë‹¨í•œ ê²€ì‚¬ë¡œ ì§ˆë³‘ ì¡°ê¸° ë°œê²¬
- **êµ¬ê°•-ì „ì‹  ê±´ê°• ì—°ê²°**: êµ¬ê°• ê±´ê°•ì´ ì „ì‹  ê±´ê°•ì˜ ì°½(window)

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. íƒ€ì•¡ ë§ˆì´í¬ë¡œë°”ì´ì˜´ì˜ ì¥ì **
- **ë¹„ì¹¨ìŠµì **: í†µì¦ ì—†ìŒ, í™˜ì compliance ë†’ìŒ
- **ì•ˆì •ì„±**: ë°˜ë³µ ìƒ˜í”Œë§ ê°€ëŠ¥
- **ë‹¤ì–‘ì„±**: 700+ ì„¸ê·  ì¢… ì„œì‹

**2. ì§ˆë³‘ë³„ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ì‹œê·¸ë‹ˆì²˜**

| ì§ˆë³‘ | ì£¼ìš” ë³€í™” | ë°”ì´ì˜¤ë§ˆì»¤ ì„¸ê·  |
|------|-----------|-----------------|
| **ë‹¹ë‡¨ë³‘** | Diversity ê°ì†Œ | *Prevotella*, *Veillonella* |
| **ì‹¬í˜ˆê´€ ì§ˆí™˜** | ì—¼ì¦ì„± ì„¸ê·  ì¦ê°€ | *Porphyromonas*, *Fusobacterium* |
| **ì•”** (êµ¬ê°•ì•” ë“±) | Dysbiosis | *Capnocytophaga*, *Veillonella* |
| **ì¹˜ì£¼ ì§ˆí™˜** | Pathogen ì¦ê°€ | *Treponema denticola* |

**3. ê¸°ìˆ ì  ì ‘ê·¼**
- **16S rRNA sequencing**: ì„¸ê·  ì¢… ë™ì •
- **Shotgun metagenomics**: ê¸°ëŠ¥ ìœ ì „ì ë¶„ì„
- **Machine learning**: ì§„ë‹¨ ëª¨ë¸ êµ¬ì¶•

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**ë°”ì´ì˜¤ì¸í¬ë§¤í‹±ìŠ¤ ì‘ìš©**:
- Salivary microbiome ë°ì´í„° ë¶„ì„ íŒŒì´í”„ë¼ì¸
- ì§ˆë³‘ ì˜ˆì¸¡ machine learning ëª¨ë¸
- ë°”ì´ì˜¤ë§ˆì»¤ taxa ë°œêµ´

**ì„ìƒ ë²ˆì—­**:
- Point-of-care diagnostic ê°œë°œ
- ê±´ê°•ê²€ì§„ í•­ëª©ìœ¼ë¡œ í™œìš©
- ê°œì¸ ë§ì¶¤ ê±´ê°• ê´€ë¦¬

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. êµ¬ê°• ë§ˆì´í¬ë¡œë°”ì´ì˜´ êµ¬ì„±**
- **Core microbiome**: *Streptococcus*, *Veillonella*, *Prevotella*, *Neisseria*
- **Niche-specific**:
  - ì¹˜ì•„ í‘œë©´: *Streptococcus mutans*
  - ì¹˜ì€: *Porphyromonas gingivalis*
  - í˜€: *Actinomyces*
  - íƒ€ì•¡: ë¶€ìœ  ì„¸ê· 

**2. Dysbiosis (ë§ˆì´í¬ë¡œë°”ì´ì˜´ ë¶ˆê· í˜•)**
- **ì •ì˜**: ì •ìƒ ë§ˆì´í¬ë¡œë°”ì´ì˜´ì˜ ê· í˜• ê¹¨ì§
- **ì›ì¸**: ì‹ì´, í•­ìƒì œ, ì§ˆë³‘, ìœ„ìƒ
- **ê²°ê³¼**: ì—¼ì¦, ì§ˆë³‘ ê°ìˆ˜ì„± ì¦ê°€

**3. 16S rRNA vs. Shotgun Metagenomics**
- **16S rRNA**:
  - ì„¸ê·  ì¢… ë™ì •
  - ë¹„ìš© ì €ë ´, ë¶„ì„ ê°„ë‹¨
  - ê¸°ëŠ¥ ì •ë³´ ì œí•œì 
- **Shotgun**:
  - ì „ì²´ ê²Œë†ˆ ì‹œí€€ì‹±
  - ê¸°ëŠ¥ ìœ ì „ì, ëŒ€ì‚¬ ê²½ë¡œ
  - ë¹„ìš© ë†’ìŒ, ë¶„ì„ ë³µì¡

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸**:
1. "íƒ€ì•¡ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ì‹œê·¸ë‹ˆì²˜ì˜ **ì¸êµ¬ ê°„ ì•ˆì •ì„±**ì€ ì–´ëŠ ì •ë„ì¸ê°€ìš”? ì‹ì´, ì§€ì—­ì— ë”°ë¼ ë‹¤ë¥¼ê¹Œìš”?"
2. "**Temporal stability** (ì‹œê°„ì  ì•ˆì •ì„±)ì€? ê°™ì€ ì‚¬ëŒì—ì„œ í•˜ë£¨ ì¤‘, ì£¼ê°„ ë³€ë™ì€?"
3. "ì§„ë‹¨ ëª¨ë¸ì˜ **sensitivity/specificity**ëŠ”? False positiveë¥¼ ì¤„ì´ëŠ” ì „ëµì€?"

---

### ğŸ”¹ ë°œí‘œ 2 (14:00-14:30)

**ì—°ì‚¬**: Che Ok Jeon (ì „ì² ì˜¥)
**ì†Œì†**: Chung-Ang University (ì¤‘ì•™ëŒ€í•™êµ)
**ì œëª©**: Amino acid-metabolizing microbes in the human gut: Hidden drivers of health and disease

#### ì—°êµ¬ ë°°ê²½

**í•µì‹¬ ì—°êµ¬ ë°©í–¥**:
- ì¥ë‚´ ë¯¸ìƒë¬¼ì˜ ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ ê²½ë¡œ
- ìˆ™ì£¼ ìƒë¦¬(ë©´ì—­, ëŒ€ì‚¬, ì‹ ê²½)ì— ë¯¸ì¹˜ëŠ” ì˜í–¥
- ì£¼ìš” ëŒ€ì‚¬ì‚°ë¬¼ì„ ìƒì„±í•˜ëŠ” íŠ¹ì • ì„¸ê·  ë¶„ë¥˜êµ°

**ì™œ ì¤‘ìš”í•œê°€**:
- **ì‹ì´-ê¸°ëŠ¥ ì—°ê²°**: ì‹ì´ êµ¬ì„±ì´ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ê¸°ëŠ¥ìœ¼ë¡œ ì–´ë–»ê²Œ ë³€í™˜ë˜ëŠ”ê°€
- **ì¹˜ë£Œ íƒ€ê²Ÿ**: íŠ¹ì • ëŒ€ì‚¬ ê²½ë¡œ ì¡°ì ˆ
- **ì •ë°€ ì˜ì–‘í•™**: ê°œì¸ ë§ì¶¤í˜• ì‹ì´ ì „ëµ

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. ì£¼ìš” ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ ê²½ë¡œ**

**Tryptophan (íŠ¸ë¦½í† íŒ) ëŒ€ì‚¬**:
```
Tryptophan
 â†“ (ì¥ë‚´ ì„¸ê· )
Indole derivatives (ì¸ëŒ ìœ ë„ì²´)
 â”œâ”€ Indole-3-acetic acid (IAA)
 â”œâ”€ Indole-3-propionic acid (IPA)
 â””â”€ Indole-3-aldehyde (IAld)
 â†“
ë©´ì—­ ì¡°ì ˆ, ì¥ ì¥ë²½ ê°•í™”, ì‹ ê²½ ë³´í˜¸
```

**ì£¼ìš” ìƒì‚° ì„¸ê· **:
- *Clostridium* spp.
- *Lactobacillus* spp.
- *Bacteroides* spp.

**Branched-Chain Amino Acids (BCAA) ëŒ€ì‚¬**:
- Leucine, Isoleucine, Valine
- ëŒ€ì‚¬: ì¥ë‚´ ì„¸ê·  â†’ ìˆ™ì£¼ ëŒ€ì‚¬ì— ì˜í–¥
- **ê³¼ë„í•œ BCAA**: ì¸ìŠë¦° ì €í•­ì„±, ë‹¹ë‡¨ë³‘
- **ì ì • BCAA**: ê·¼ìœ¡ í•©ì„±, ì—ë„ˆì§€ ëŒ€ì‚¬

**Aromatic Amino Acids (ë°©í–¥ì¡± ì•„ë¯¸ë…¸ì‚°)**:
- Tryptophan â†’ Serotonin ì „êµ¬ì²´
- Tyrosine â†’ Dopamine ì „êµ¬ì²´
- Phenylalanine â†’ Tyrosine â†’ Catecholamines

**2. ê±´ê°•/ì§ˆë³‘ì— ë¯¸ì¹˜ëŠ” ì˜í–¥**

| ëŒ€ì‚¬ì‚°ë¬¼ | ê¸°ëŠ¥ | ê±´ê°• íš¨ê³¼ | ì§ˆë³‘ ì—°ê´€ |
|----------|------|-----------|-----------|
| **Indole-3-propionic acid** | í•­ì‚°í™”, ì‹ ê²½ë³´í˜¸ | ë‡Œ ê±´ê°• | ì•Œì¸ í•˜ì´ë¨¸ ë‚®ìŒ |
| **Short-chain fatty acids** | í•­ì—¼ì¦ | ëŒ€ì¥ ê±´ê°• | IBD ë‚®ìŒ |
| **Trimethylamine (TMA)** | ì½œë ˆìŠ¤í…Œë¡¤ ëŒ€ì‚¬ | - | ì‹¬í˜ˆê´€ ì§ˆí™˜ ë†’ìŒ |
| **Hydrogen sulfide** | ì¥ ìš´ë™ì„± | ì ì •ëŸ‰ í•„ìš” | ê³¼ë„ ì‹œ ì—¼ì¦ |

**3. íŠ¹ì • ì„¸ê· ì˜ ì—­í• **

**Indole ìƒì‚°ê· **:
- *Clostridium sporogenes*
- *Escherichia coli*
- *Bacteroides thetaiotaomicron*

**SCFA ìƒì‚°ê· ** (ê°„ì ‘ì  ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬):
- *Faecalibacterium prausnitzii*
- *Roseburia* spp.
- *Eubacterium* spp.

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**ë©”íƒ€ê²Œë…¸ë¯¹ìŠ¤/ë©”íƒ€ë³¼ë¡œë¯¹ìŠ¤ í†µí•©**:
- ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ ìœ ì „ì abundance ì¸¡ì •
- ëŒ€ì‚¬ì‚°ë¬¼ ì •ëŸ‰ (LC-MS/MS)
- ìœ ì „ì-ëŒ€ì‚¬ì‚°ë¬¼ correlation

**ì„ìƒ ì‘ìš©**:
- ê°œì¸ë³„ ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ í”„ë¡œíŒŒì¼ë§
- ì‹ì´ ì²˜ë°© (íŠ¹ì • ì•„ë¯¸ë…¸ì‚° ì¡°ì ˆ)
- Prebiotics/probiotics ì„ íƒ (ëŒ€ì‚¬ ëŠ¥ë ¥ ê¸°ë°˜)

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. ì¥ë‚´ ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ vs. ìˆ™ì£¼ ëŒ€ì‚¬**
- **Dietary protein** â†’ Amino acids
  - **Absorbed** (ì†Œì¥): ìˆ™ì£¼ ëŒ€ì‚¬
  - **Unabsorbed** (ëŒ€ì¥): ë¯¸ìƒë¬¼ ëŒ€ì‚¬

**2. Gut-Brain Axis (ì¥-ë‡Œ ì¶•)**
- ì¥ë‚´ ë¯¸ìƒë¬¼ ëŒ€ì‚¬ì‚°ë¬¼ â†’ Vagus nerve ìê·¹
- Tryptophan â†’ Serotonin (90%ëŠ” ì¥ì—ì„œ ìƒì‚°)
- SCFA â†’ Blood-brain barrier í†µê³¼ â†’ ì‹ ê²½ ë³´í˜¸

**3. Metabolic Modeling**
- **Genome-scale models**: ë¯¸ìƒë¬¼ ëŒ€ì‚¬ ê²½ë¡œ ì˜ˆì¸¡
- **Community modeling**: ë¯¸ìƒë¬¼ ê°„ ìƒí˜¸ì‘ìš©
- **Flux balance analysis**: ëŒ€ì‚¬ íë¦„ ìµœì í™”

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸**:
1. "ì–´ë–¤ **ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ì‚°ë¬¼ì´ ê°€ì¥ ê°•ë ¥í•œ ê±´ê°• íš¨ê³¼** ì¦ê±°ë¥¼ ê°€ì§€ê³  ìˆë‚˜ìš”?"
2. "íŠ¹ì • **ëŒ€ì‚¬ ê²½ë¡œë¥¼ íƒ€ê²ŸíŒ…**í•˜ë ¤ë©´ ì–´ë–¤ probiotic/prebioticì„ ì‚¬ìš©í•´ì•¼ í•˜ë‚˜ìš”?"
3. "**ê°œì¸ ê°„ variability**ê°€ í¬ë‹¤ë©´, ë§ì¶¤í˜• ì‹ì´ ì²˜ë°©ì´ ê°€ëŠ¥í•œê°€ìš”?"
4. "ë©”íƒ€ê²Œë…¸ë¯¹ ë°ì´í„°ì—ì„œ **ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ ëŠ¥ë ¥ì„ ì˜ˆì¸¡**í•˜ëŠ” ë§ˆì»¤ëŠ”?"

---

### ğŸ”¹ ë°œí‘œ 3 (14:30-15:00)

**ì—°ì‚¬**: Joo Hong Park (ë°•ì£¼í™)
**ì†Œì†**: Seoul National University (ì„œìš¸ëŒ€í•™êµ)
**ì œëª©**: Adaptive strategies of gut symbionts for colonization under dietary shifts

#### ì—°êµ¬ ë°°ê²½

**í•µì‹¬ ì—°êµ¬ ë°©í–¥**:
- ì¥ë‚´ ì„¸ê· ì´ ë³€í™”í•˜ëŠ” ì˜ì–‘ í™˜ê²½ì— ì ì‘í•˜ëŠ” ë°©ë²•
- ê²½ìŸê³¼ niche specialization
- ëŒ€ì‚¬ì  ìœ ì—°ì„±ê³¼ colonization resistance

**ì™œ ì¤‘ìš”í•œê°€**:
- **ë§ˆì´í¬ë¡œë°”ì´ì˜´ resilience** ì´í•´
- **íš¨ê³¼ì ì¸ probiotic ì„¤ê³„**
- **ì‹ì´ ë³€í™”ì— ëŒ€í•œ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ë°˜ì‘ ì˜ˆì¸¡**

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. Dietary Shifts (ì‹ì´ ë³€í™”)**

**ì˜ˆì‹œ**:
- **High-fat diet** â†’ **High-fiber diet**
- **Western diet** â†’ **Mediterranean diet**
- **Protein-rich** â†’ **Carbohydrate-rich**

**ë§ˆì´í¬ë¡œë°”ì´ì˜´ ë°˜ì‘**:
- **Short-term** (ìˆ˜ì¼): ë¹ ë¥¸ taxa ë³€í™”
- **Long-term** (ìˆ˜ì£¼): ì•ˆì •í™”, ìƒˆë¡œìš´ í‰í˜•

**2. Adaptive Strategies (ì ì‘ ì „ëµ)**

**Strategy 1: Metabolic Flexibility**
- **Generalists**: ë‹¤ì–‘í•œ ê¸°ì§ˆ ì‚¬ìš© ê°€ëŠ¥
  - ì˜ˆ: *Bacteroides* spp. (polysaccharide utilization loci - PUL)
  - 200+ PULs â†’ ë‹¤ì–‘í•œ íƒ„ìˆ˜í™”ë¬¼ ë¶„í•´
- **Specialists**: íŠ¹ì • ê¸°ì§ˆì— íŠ¹í™”
  - ì˜ˆ: *Ruminococcus bromii* (resistant starch)

**Strategy 2: Competitive Exclusion**
- **Bacteriocin production**: ê²½ìŸì ì–µì œ
- **Nutrient scavenging**: ë¹ ë¥¸ ì˜ì–‘ì†Œ íšë“
- **Biofilm formation**: Niche ì„ ì 

**Strategy 3: Mutualism**
- **Cross-feeding**: í•œ ì„¸ê· ì˜ ëŒ€ì‚¬ì‚°ë¬¼ = ë‹¤ë¥¸ ì„¸ê· ì˜ ì˜ì–‘ì†Œ
- ì˜ˆ: *B. thetaiotaomicron* (ì„¬ìœ ì†Œ ë¶„í•´) â†’ *F. prausnitzii* (acetate ì†Œë¹„ â†’ butyrate ìƒì‚°)

**3. Colonization Resistance**

**ì •ì˜**: ê¸°ì¡´ ë§ˆì´í¬ë¡œë°”ì´ì˜´ì´ ì™¸ë˜ ì„¸ê·  ì •ì°©ì„ ë°©í•´

**ë©”ì»¤ë‹ˆì¦˜**:
- **Niche saturation**: ëª¨ë“  niche ì ìœ 
- **Nutrient competition**: ì˜ì–‘ì†Œ ê³ ê°ˆ
- **Antimicrobial production**: Bacteriocins, SCFAs (pH ë‚®ì¶¤)
- **Immune stimulation**: IgA, AMPs

**ì‹ì´ì™€ì˜ ê´€ê³„**:
- **High-fiber diet**: Colonization resistance â†‘ (SCFA ìƒì‚°)
- **Antibiotic use**: Colonization resistance â†“ â†’ C. difficile ê°ì—¼ ìœ„í—˜

**4. Probiotic ì„¤ê³„ í•¨ì˜**

**íš¨ê³¼ì ì¸ probiotic ì „ëµ**:
- **Dietary conditioning**: íŠ¹ì • ì‹ì´ì™€ í•¨ê»˜ íˆ¬ì—¬
- **Metabolic compatibility**: ì¥ë‚´ ì˜ì–‘ì†Œ í™˜ê²½ì— ë§ëŠ” ê· ì£¼
- **Persistence factors**: Bile resistance, acid tolerance

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**ë©”íƒ€ê²Œë…¸ë¯¹ìŠ¤ ì‹œê³„ì—´ ë¶„ì„**:
- ì‹ì´ ë³€í™” ì „í›„ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ë³€í™” ì¶”ì 
- Adaptive genes (PULs, metabolic pathways) abundance ë³€í™”
- Community dynamics modeling

**Probiotic ê°œë°œ**:
- íŠ¹ì • ì‹ì´ì— ìµœì í™”ëœ ê· ì£¼ ì„ íƒ
- Colonization ëŠ¥ë ¥ ì˜ˆì¸¡ (ìœ ì „ì ë§ˆì»¤)

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. Polysaccharide Utilization Loci (PULs)**
- **êµ¬ì¡°**: susC/susD (outer membrane transporters) + CAZymes
- **ê¸°ëŠ¥**: ë³µì¡í•œ ë‹¤ë‹¹ë¥˜ ë¶„í•´ ë° ìˆ˜ì†¡
- **ë‹¤ì–‘ì„±**: *Bacteroides* 1ì¢… = 100+ PULs

**2. Cross-Feeding Networks**
```
Fiber (resistant starch)
  â†“
B. thetaiotaomicron (ë¶„í•´)
  â†“
Oligosaccharides, Acetate
  â†“
F. prausnitzii (ì†Œë¹„)
  â†“
Butyrate (ìˆ™ì£¼ì— ìœ ìµ)
```

**3. Colonization Resistance Mechanisms**
- **Direct**: Bacteriocin, hydrogen peroxide, organic acids
- **Indirect**: Bile acid ë³€í™˜ (secondary bile acids â†’ pathogen ì–µì œ)

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸**:
1. "ì–´ë–¤ **dietary shiftê°€ ê°€ì¥ ì˜ˆì¸¡ ê°€ëŠ¥í•œ** ë§ˆì´í¬ë¡œë°”ì´ì˜´ ë³€í™”ë¥¼ ì¼ìœ¼í‚¤ë‚˜ìš”?"
2. "Probiotic íˆ¬ì—¬ ì‹œ **ì–´ë–¤ ì‹ì´ê°€ colonizationì„ ë„ì™€**ì£¼ë‚˜ìš”?"
3. "**ë©”íƒ€ê²Œë…¸ë¯¹ ë°ì´í„°ë§Œìœ¼ë¡œ colonization potential**ì„ ì˜ˆì¸¡í•  ìˆ˜ ìˆë‚˜ìš”?"
4. "ì‹ì´ ë³€í™” íš¨ê³¼ê°€ **ì–¼ë§ˆë‚˜ ì˜¤ë˜ ì§€ì†**ë˜ë‚˜ìš”? Reversible?"

---

### ğŸ”¹ ë°œí‘œ 4 (15:00-15:30)

**ì—°ì‚¬**: Ravinder Nagpal
**ì†Œì†**: Florida State University, USA
**ì œëª©**: Unveiling the role of diet-microbiome interactions in human health and disease

#### ì—°êµ¬ ë°°ê²½

**í•µì‹¬ ì—°êµ¬ ë°©í–¥**:
- í¬ê´„ì  diet-microbiome-health axis ì—°êµ¬
- ë§ˆì´í¬ë¡œë°”ì´ì˜´ ì¡°ì ˆì„ ìœ„í•œ ì‹ì´ ì¤‘ì¬
- ì„ìƒ ì‹¤ë¬´ë¡œì˜ ë²ˆì—­

**ì™œ ì¤‘ìš”í•œê°€**:
- **êµ­ì œì  ê´€ì **: ê¸€ë¡œë²Œ ë§ˆì´í¬ë¡œë°”ì´ì˜´-ì˜ì–‘ ì—°êµ¬
- **ê·¼ê±° ê¸°ë°˜ ì‹ì´ ê¶Œì¥ì‚¬í•­**
- **ì—°êµ¬ì™€ ê³µì¤‘ë³´ê±´ ì—°ê²°**

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. Diet-Microbiome-Health Axis**

```
Diet
 â†“
Microbiome Composition
 â†“
Microbial Metabolites
 â†“
Host Physiology
 â”œâ”€ Immune function
 â”œâ”€ Metabolism
 â”œâ”€ Brain function
 â””â”€ Disease risk
```

**2. ì£¼ìš” ì‹ì´ íŒ¨í„´ë³„ íš¨ê³¼**

**Mediterranean Diet**:
- â†‘ Fiber, polyphenols, omega-3
- â†‘ *Faecalibacterium*, *Roseburia* (SCFA producers)
- â†“ Inflammation markers
- â†“ Cardiovascular disease, diabetes

**Western Diet**:
- â†‘ Fat, sugar, processed foods
- â†‘ *Bilophila*, *Alistipes* (bile-tolerant)
- â†‘ LPS, inflammation
- â†‘ Obesity, metabolic syndrome

**High-Fiber Diet**:
- â†‘ SCFA production
- â†‘ Diversity
- â†‘ Gut barrier function
- â†“ Colon cancer risk

**3. Evidence-Based Dietary Recommendations**

**ëª©í‘œë³„ ì‹ì´ ì „ëµ**:

| ëª©í‘œ | ì‹ì´ ê¶Œì¥ì‚¬í•­ | ì£¼ìš” ì‹í’ˆ | ë©”ì»¤ë‹ˆì¦˜ |
|------|--------------|----------|----------|
| **Diversity â†‘** | Varied plant foods | 30+ ì‹ë¬¼ ì¢…/ì£¼ | ë‹¤ì–‘í•œ ì„¬ìœ ì†Œ |
| **SCFA â†‘** | Resistant starch, inulin | ê°ì, ë°”ë‚˜ë‚˜, ë§ˆëŠ˜ | Fermentation |
| **Inflammation â†“** | Omega-3, polyphenols | ìƒì„ , ë² ë¦¬, ë…¹ì°¨ | Anti-inflammatory |
| **Weight loss** | Low glycemic, high fiber | í†µê³¡ë¬¼, ì±„ì†Œ | Satiety, metabolism |

**4. Clinical Translation**

**Challenges**:
- **Individual variability**: ê°™ì€ ì‹ì´ â†’ ë‹¤ë¥¸ ë°˜ì‘
- **Compliance**: ì¥ê¸° ì‹ì´ ë³€í™” ì–´ë ¤ì›€
- **Confounding factors**: ìƒí™œìŠµê´€, ìœ ì „ì

**Solutions**:
- **Personalized nutrition**: ê°œì¸ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ê¸°ë°˜ ì²˜ë°©
- **Microbiome testing**: Baseline profiling
- **Monitoring**: ì •ê¸°ì  ë§ˆì´í¬ë¡œë°”ì´ì˜´ ì¶”ì 

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**Public Health Applications**:
- ì¸êµ¬ ìˆ˜ì¤€ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ë°ì´í„° ìˆ˜ì§‘
- ì‹ì´ ê°€ì´ë“œë¼ì¸ì— ë§ˆì´í¬ë¡œë°”ì´ì˜´ ê³ ë ¤
- Health policyì— ê·¼ê±° ì œê³µ

**ì—°êµ¬ ì„¤ê³„**:
- Diet intervention study design
- Microbiome + clinical outcomes integration
- Longitudinal analysis

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸**:
1. "**Personalized nutrition êµ¬í˜„**ì˜ í˜„ì‹¤ì  ì¥ë²½ì€? ë¹„ìš©, ì ‘ê·¼ì„±?"
2. "ì–´ë–¤ **baseline microbiome metrics**ê°€ dietary response ì˜ˆì¸¡ì— ìœ ìš©í•œê°€ìš”?"
3. "**í•œêµ­ ì‹ì´ íŒ¨í„´** (ê¹€ì¹˜, ëœì¥ ë“±)ì˜ ë§ˆì´í¬ë¡œë°”ì´ì˜´ íš¨ê³¼ ì—°êµ¬ê°€ ìˆë‚˜ìš”?"
4. "ì‹ì´ ì¤‘ì¬ì˜ **íš¨ê³¼ ì§€ì† ê¸°ê°„**ì€? ì‹ì´ ì¤‘ë‹¨ í›„ ì–¼ë§ˆë‚˜ ìœ ì§€?"

---

## ğŸ§  ì„¸ì…˜ ì „ì²´ í•µì‹¬ ê°œë… ì •ë¦¬

### í•„ìˆ˜ ì•”ê¸° ì‚¬í•­

**1. Diet-Microbiome-Health Connections**

| ì‹ì´ ìš”ì†Œ | ë§ˆì´í¬ë¡œë°”ì´ì˜´ ë³€í™” | ê±´ê°• íš¨ê³¼ |
|-----------|---------------------|-----------|
| **Fiber** | SCFA producers â†‘ | Colon health, immunity |
| **Polyphenols** | *Akkermansia* â†‘ | Metabolic health |
| **Protein** | Proteolytic bacteria â†‘ | ê³¼ë„ ì‹œ harmful metabolites |
| **Fat** | Bile-tolerant bacteria â†‘ | Inflammation |

**2. ì£¼ìš” Metabolites & Functions**

- **Short-Chain Fatty Acids (SCFAs)**: Butyrate, Acetate, Propionate â†’ í•­ì—¼ì¦, ì¥ë²½ ê°•í™”
- **Indole derivatives**: Tryptophan ëŒ€ì‚¬ â†’ ë©´ì—­ ì¡°ì ˆ, ì‹ ê²½ ë³´í˜¸
- **Trimethylamine-N-oxide (TMAO)**: Choline/Carnitine â†’ ì‹¬í˜ˆê´€ ì§ˆí™˜ (ë†’ìœ¼ë©´ ë‚˜ì¨)
- **Secondary bile acids**: ë¯¸ìƒë¬¼ ë³€í™˜ â†’ ì¥ ê±´ê°• (ì ì •ëŸ‰)

**3. Key Bacterial Taxa**

- ***Faecalibacterium prausnitzii***: Butyrate producer, anti-inflammatory
- ***Akkermansia muciniphila***: Mucin degrader, metabolic health
- ***Bacteroides* spp.**: Polysaccharide degraders, metabolic flexibility
- ***Prevotella* spp.**: Fiber degraders, plant-rich diet marker

---

## ğŸ“š ì‚¬ì „ ì½ê¸° ìë£Œ

### í•„ìˆ˜ (Must Read)

1. **"Diet-Microbiome Interactions"** (2024, Nature Reviews)
   - ìµœì‹  review, ì „ì²´ axis ì´í•´

2. **"Gut Microbiome and Personalized Nutrition"** (2023)
   - ê°œì¸ ë§ì¶¤ ì˜ì–‘í•™ì˜ í˜„ì¬ì™€ ë¯¸ë˜

### ì¶”ì²œ (Recommended)

3. **Jin-Woo Bae Lab Publications**
   - íƒ€ì•¡ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ì§„ë‹¨ ì—°êµ¬

4. **"Amino Acid Metabolism by Gut Microbiota"** (2022, Cell Metabolism)

---

## ğŸ¤ ì¤€ë¹„í•  ì§ˆë¬¸ ë¦¬ìŠ¤íŠ¸

### Top Questions

1. **[Bae]** "íƒ€ì•¡ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ì§„ë‹¨ ìƒìš©í™”ì˜ ì£¼ìš” ì¥ë²½ì€? ê¸°ìˆ ì ? ê·œì œì ?"
2. **[Jeon]** "ì–´ë–¤ ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ ê²½ë¡œê°€ **ê°€ì¥ promising therapeutic target**ì¸ê°€ìš”?"
3. **[Park]** "Probiotic colonization ì„±ê³µë¥ ì„ ë†’ì´ê¸° ìœ„í•œ **optimal diet conditioning** ì „ëµì€?"
4. **[Nagpal]** "Personalized nutritionì´ ì‹¤ì œ ê³µì¤‘ë³´ê±´ ì •ì±…ì— ë°˜ì˜ë˜ë ¤ë©´ ì–´ë–¤ ê·¼ê±°ê°€ í•„ìš”í•œê°€ìš”?"

---

## ğŸ¤ ë„¤íŠ¸ì›Œí‚¹ ì „ëµ

### ìš°ì„ ìˆœìœ„ ì—°ì‚¬

**1. Che Ok Jeon (ì „ì² ì˜¥)** - ì¤‘ì•™ëŒ€
- ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ ì „ë¬¸ê°€
- ë©”íƒ€ë³¼ë¡œë¯¹ìŠ¤ + ë©”íƒ€ê²Œë…¸ë¯¹ìŠ¤ í†µí•©
- í•œêµ­ ì—°êµ¬ì â†’ í˜‘ë ¥ ê°€ëŠ¥ì„±

**2. Joo Hong Park (ë°•ì£¼í™)** - ì„œìš¸ëŒ€
- Colonization ë©”ì»¤ë‹ˆì¦˜
- Probiotic ì„¤ê³„ í•¨ì˜
- ì§€ë¦¬ì  ê·¼ì ‘ì„±

**3. Jin-Woo Bae (ë°°ì§„ìš°)** - ê²½í¬ëŒ€
- ì§„ë‹¨ ì‘ìš©
- íƒ€ì•¡ ë§ˆì´í¬ë¡œë°”ì´ì˜´ ë°ì´í„°ë² ì´ìŠ¤

---

## âš¡ ì„¸ì…˜ ë‹¹ì¼ ì²´í¬ë¦¬ìŠ¤íŠ¸

### ì‚¬ì „ ì¤€ë¹„
- [ ] ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ ê²½ë¡œ ë³µìŠµ
- [ ] PULs, cross-feeding ê°œë… ìˆ™ì§€
- [ ] ì—°ì‚¬ ìµœê·¼ ë…¼ë¬¸ abstract ì½ê¸°
- [ ] ì§ˆë¬¸ ë¦¬ìŠ¤íŠ¸ ì¤€ë¹„

### ì„¸ì…˜ ì¤‘
- [ ] í•µì‹¬ í¬ì¸íŠ¸ ë©”ëª¨
- [ ] ë°œí‘œ ìŠ¬ë¼ì´ë“œ ì‚¬ì§„ (í—ˆìš© ì‹œ)
- [ ] ì‹¤ì‹œê°„ ì§ˆë¬¸ ë©”ëª¨

### ì„¸ì…˜ í›„
- [ ] ì—°ì‚¬ 3ëª…ê³¼ ëŒ€í™”
- [ ] ëª…í•¨ êµí™˜
- [ ] Follow-up ê³„íš

---

## ğŸ”— ë‹¤ë¥¸ ì„¸ì…˜ê³¼ì˜ ì—°ê²°

**S9 (Kimchi Biobank)ì™€ ì—°ê³„**:
- ë°œíš¨ ì‹í’ˆ ë§ˆì´í¬ë¡œë°”ì´ì˜´
- í•œêµ­ ì „í†µ ì‹ì´ì˜ ê±´ê°• íš¨ê³¼

**S11 (Microbiome to Industry)ì™€ ì—°ê³„**:
- Probiotic/prebiotic ê°œë°œ
- ê¸°ëŠ¥ì„± ì‹í’ˆ ìƒìš©í™”

**S15 (Gut-Skin Axis)ì™€ ì—°ê³„**:
- ì‹ì´ â†’ ì¥ â†’ í”¼ë¶€ ì—°ê²°
- ì‹ì´ ì¡°ì ˆì„ í†µí•œ í”¼ë¶€ ê±´ê°•

---

**ì´ ì„¸ì…˜ í›„ ë‹¹ì‹ ì€**:
âœ… Diet-microbiome-health axis ì´í•´
âœ… ì£¼ìš” ì•„ë¯¸ë…¸ì‚° ëŒ€ì‚¬ ê²½ë¡œ íŒŒì•…
âœ… Colonization ì „ëµ ìŠµë“
âœ… ì„ìƒ ì‘ìš© ê°€ëŠ¥ì„± í‰ê°€
